Douglas B. Snyder - Net Worth and Insider Trading
Douglas B. Snyder Net Worth
The estimated net worth of Douglas B. Snyder is at least $14 Million dollars as of 2024-12-01. Douglas B. Snyder is the Chief Legal Officer of GW Pharmaceuticals PLC and owns about 61,848 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $14 Million. Details can be seen in Douglas B. Snyder's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas B. Snyder has not made any transactions after 2021-03-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas B. Snyder
Douglas B. Snyder Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas B. Snyder owns 1 companies in total, including GW Pharmaceuticals PLC (GWPH) .
Click here to see the complete history of Douglas B. Snyder’s form 4 insider trades.
Insider Ownership Summary of Douglas B. Snyder
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
GWPH | GW Pharmaceuticals PLC | 2021-03-26 | Chief Legal Officer |
Douglas B. Snyder Latest Holdings Summary
Douglas B. Snyder currently owns a total of 1 stock. Douglas B. Snyder owns 61,848 shares of GW Pharmaceuticals PLC (GWPH) as of March 26, 2021, with a value of $14 Million.
Latest Holdings of Douglas B. Snyder
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GWPH | GW Pharmaceuticals PLC | 2021-03-26 | 61,848 | 218.96 | 13,542,238 |
Holding Weightings of Douglas B. Snyder
Douglas B. Snyder Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas B. Snyder has made a total of 7 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 8,400 shares on March 26, 2021, which brought Douglas B. Snyder around $152,208.
Insider Trading History of Douglas B. Snyder
- 1
Douglas B. Snyder Trading Performance
Douglas B. Snyder Ownership Network
Douglas B. Snyder Owned Company Details
What does GW Pharmaceuticals PLC do?
Who are the key executives at GW Pharmaceuticals PLC?
Douglas B. Snyder is the Chief Legal Officer of GW Pharmaceuticals PLC. Other key executives at GW Pharmaceuticals PLC include Chief Medical Officer Volker Knappertz , Secretary Adam D. George , and director & Executive Chairman Guy Geoffrey W Dr .
GW Pharmaceuticals PLC (GWPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of GW Pharmaceuticals PLC (GWPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GW Pharmaceuticals PLC (GWPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
GW Pharmaceuticals PLC (GWPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
GW Pharmaceuticals PLC Insider Transactions
Douglas B. Snyder Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas B. Snyder. You might contact Douglas B. Snyder via mailing address: Sovereign House, Vision Park, Histon Cambridge X0 Cb249bz.